Indore | IAS GS Foundation Course | 9 May, 6:30 PM Call Us
This just in:

State PCS

Daily Updates


Important Facts For Prelims

India Nears Kala Azar Elimination

  • 12 Dec 2023
  • 3 min read

Source: IE

Why in News?

India stands on the brink of eliminating visceral leishmaniasis, commonly known as kala azar. With a marked decline in reported cases and deaths, the nation has come close to meeting the elimination target set by the World Health Organization (WHO).

  • Bangladesh, India's neighbour, was the first country validated by the WHO for eliminating kala azar as a public health problem.

What is Kala-Azar?

  • About:
    • Visceral leishmaniasis commonly known as kala-azar, is a slow-progressing indigenous disease caused by a protozoan parasite of genus Leishmania.
      • It is also known as Black Fever or Dumdum Fever.
      • In India Leishmania donovani is the only parasite causing this disease.
  • Transmission and Symptoms:
    • It is transmitted by sandflies. Sandflies of the genus Phlebotomus argentipes are the only known vectors of kala-azar in India.
    • It causes fever, weight loss, and spleen and liver enlargement. If left untreated, it can be fatal in 95% of cases.
  • Recorded Cases in India:
    • India documented 530 cases and four deaths in 2023, a decline from previous years.
      • Additionally, there were 286 cases of post-kala azar dermal leishmaniasis (PKDL).
  • Post Kala-azar Dermal Leishmaniasis (PKDL):
    • This condition arises when Leishmania donovani infiltrates and thrives within skin cells, resulting in the formation of skin lesions.
    • In some instances of kala-azar, PKDL emerges after treatment, but now it is believed that PKDL might occur without going through the visceral stage. However, more data is needed to understand how PKDL develops.
      • The visceral stage refers to the initial phase of visceral leishmaniasis (kala-azar), where the parasite affects internal organs.
  • Treatment:
    • In India, the primary treatment for kala-azar involves administering injectable liposomal amphotericin B.
      • For PKDL, the standard treatment consists of 12 weeks of oral miltefosine, with the dosage adjusted based on the patient's age and weight.
  • Strategies for Elimination in India:
    • Effective Spraying: Rigorous monitoring of indoor residual spraying to curb sandfly breeding and disease spread.
    • Wall Plastering: Using Gerrard soil for wall plastering to minimize sandfly breeding areas.
    • Treatment Compliance: Ensuring completion of PKDL treatment through the ASHA (Accredited Social Health Activist) network.

Note

WHO has set a target of 2030 to eliminate Kala-azar. The WHO's Neglected Tropical Diseases Road map also includes this target.

  • Government of India launched a centrally sponsored Kala-azar control Programme in 1990-91. The National Health Policy (2002) envisaged kala-azar Elimination by 2010 which was revised later to 2015. Now Kala-azar is targeted for elimination by 2023 in India.

close
SMS Alerts
Share Page
images-2
images-2